Chris Halyk
Direktor/Vorstandsmitglied bei MEDIPHARM LABS CORP.
Vermögen: 5 160 $ am 30.04.2024
Aktive Positionen von Chris Halyk
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MEDIPHARM LABS CORP. | Direktor/Vorstandsmitglied | 04.08.2020 | - |
Independent Dir/Board Member | 04.08.2020 | - |
Karriereverlauf von Chris Halyk
Ehemalige bekannte Positionen von Chris Halyk
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Präsident | 01.01.2006 | 01.01.2019 |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Direktor/Vorstandsmitglied | 01.01.2012 | 01.01.2013 |
Ortho Biotech, Inc. | Corporate Officer/Principal | - | - |
Ausbildung von Chris Halyk
Richard Ivey School of Business | Undergraduate Degree |
Statistik
International
Kanada | 5 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 2 |
President | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MEDIPHARM LABS CORP. | Process Industries |
Private Unternehmen | 3 |
---|---|
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
Ortho Biotech, Inc. |
- Börse
- Insiders
- Chris Halyk
- Erfahrung